Wayne Threatt - 15 Jun 2022 Form 4 Insider Report for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Jun 2022, 20:02:30 UTC
Prior SEC filing
14 Jun 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Wayne Threatt

Key filing fact

Wayne Threatt filed Form 4 for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN) on 17 Jun 2022.

Key facts

  • This page summarizes Wayne Threatt's Form 4 filing for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Jun 2022, 20:02.

Change

  • Previous filing in this sequence was filed on 14 Jun 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ADN transaction

Common Stock

Award

Transaction value
$0
Shares
+64,516
Change %
Price
$0.000000
Shares after
64,516
Date
15 Jun 2022
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Restricted stock units ("RSUs") granted pursuant to Issuer's 2021 Equity Incentive Plan as part of Reporting Person's compensation for service as a director of Issuer. The RSUs represent a contingent right to receive common stock of Issuer upon vesting. The RSUs vest 100% on either June 8, 2023, which is the first anniversary of the vesting commencement date, or as of the 2023 annual meeting of stockholders of Issuer, whichever is earlier.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .